• Home

  • Documents

  • Clarifying FDA's Expectations for Appropriate Excipient Controls in 2013 - FDASIA, GDUFA, QbD, & IID...

If you can't read please download the document

Clarifying FDA's Expectations for Appropriate Excipient Controls in 2013 - FDASIA, GDUFA, QbD, & IID Impact Total Excipient Control (TEC) David R. Schoneker

Embed Size (px)

Day2.2 - Lionberger - GDUFA Regulatory Science

Day2.2 - Lionberger - GDUFA Regulatory Science

Documents
FDASIA Regulations Subcommittee

FDASIA Regulations Subcommittee

Documents
EXCIPIENT PERFORMANCEtriphasepharmasolutions.com/Private/USP 1059 EXCIPIENT...USP 35 General Information / 〈1059〉 Excipient Performance599 This general chapter provides

EXCIPIENT PERFORMANCEtriphasepharmasolutions.com/Private/USP 1059 EXCIPIENT...USP 35 General Information / 〈1059〉 Excipient Performance599 This general chapter provides

Documents
FDASIA Taxonomy Subgroup HIT Policy Committee FDASIA Workgroup On Site Meeting 30 May 2013

FDASIA Taxonomy Subgroup HIT Policy Committee FDASIA Workgroup On Site Meeting 30 May 2013

Documents
GDUFA Regulatory Science - gphaonline.org · GDUFA Regulatory Science ... – Dosage form specific QbD for complex products ... – IVIVC and Clinical trial simulation support of

GDUFA Regulatory Science - gphaonline.org · GDUFA Regulatory Science ... – Dosage form specific QbD for complex products ... – IVIVC and Clinical trial simulation support of

Documents
FDA Safety and Innovation Act (FDASIA): GMP Inspection …...FDA Safety and Innovation Act (FDASIA): GMP Inspection Impact ©2013 PAREXEL Consulting Agenda Overview of the FDASIA Legislation

FDA Safety and Innovation Act (FDASIA): GMP Inspection …...FDA Safety and Innovation Act (FDASIA): GMP Inspection Impact ©2013 PAREXEL Consulting Agenda Overview of the FDASIA Legislation

Documents
PQRI Opening Session 1 PQRI Survey of Pharmaceutical Excipient Testing and Control Strategies Used by Excipient Manufacturers, Excipient Distributors and

PQRI Opening Session 1 PQRI Survey of Pharmaceutical Excipient Testing and Control Strategies Used by Excipient Manufacturers, Excipient Distributors and

Documents
FDASIA WG Regulations Sub-Group Report Out

FDASIA WG Regulations Sub-Group Report Out

Documents
Day2.6 - Park - GDUFA Review Efficiency Enhancements

Day2.6 - Park - GDUFA Review Efficiency Enhancements

Documents
Generic Drug User Fee Act Reauthorization GDUFA II

Generic Drug User Fee Act Reauthorization GDUFA II

Documents
Excipient Table 1

Excipient Table 1

Documents
Excipient Auditing

Excipient Auditing

Documents
HIT Policy Committee FDASIA Workgroup Regulation Subgroup ... · 7/12/2013  · HIT Policy Committee FDASIA Workgroup Regulation Subgroup Transcript ... Coordinator Thank you. Good

HIT Policy Committee FDASIA Workgroup Regulation Subgroup ... · 7/12/2013  · HIT Policy Committee FDASIA Workgroup Regulation Subgroup Transcript ... Coordinator Thank you. Good

Documents
FDA Testimony - Implementation of GDUFA (2!4!16)

FDA Testimony - Implementation of GDUFA (2!4!16)

Documents
Day1.6 - Zhang - DMFs With a GDUFA Perspective

Day1.6 - Zhang - DMFs With a GDUFA Perspective

Documents
Cyclodextrins as a Excipient

Cyclodextrins as a Excipient

Documents
FDASIA Regulations SubGROUP

FDASIA Regulations SubGROUP

Documents
DRUG MASTER FILES UNDER GDUFA: DMF Basics

DRUG MASTER FILES UNDER GDUFA: DMF Basics

Documents
Trinity College Dublin QP Forum Excipient Risk Assessment Workshop · 2019-11-05 · the excipient manufacturing site based on the excipient risk profile? o By performing the excipient

Trinity College Dublin QP Forum Excipient Risk Assessment Workshop · 2019-11-05 · the excipient manufacturing site based on the excipient risk profile? o By performing the excipient

Documents
FDASIA Taxonomy Subgroup HIT Policy Committee FDASIA Workgroup Virtual Meeting 14 June 2013

FDASIA Taxonomy Subgroup HIT Policy Committee FDASIA Workgroup Virtual Meeting 14 June 2013

Documents
Formalized Risk Assessment for Excipients• Excipient origin and potential for contamination • Excipient complexity (composite) • Prior knowledge of and experience with excipient

Formalized Risk Assessment for Excipients• Excipient origin and potential for contamination • Excipient complexity (composite) • Prior knowledge of and experience with excipient

Documents
Excipient Qualification Guide

Excipient Qualification Guide

Documents
DRAFT FDASIA Committee Report

DRAFT FDASIA Committee Report

Documents
Excipient Cours

Excipient Cours

Documents
GDUFA Regulatory Science Update (PDF - 2517KB)

GDUFA Regulatory Science Update (PDF - 2517KB)

Documents
FDASIA health IT report [PDF - 438 KB]

FDASIA health IT report [PDF - 438 KB]

Documents
FDASIA Health IT Report

FDASIA Health IT Report

Documents
EXCIPIENT ESSENTIALS

EXCIPIENT ESSENTIALS

Documents
GDUFA Research Update on Mechanistic Modeling Approaches

GDUFA Research Update on Mechanistic Modeling Approaches

Documents
Drug Excipient Compatibility Study

Drug Excipient Compatibility Study

Documents